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Abstract  Article Info 
Introduction: Nasopharyngeal Carcinoma (NPC) is a type of epithelial carcinoma that arises from the 
nasopharynx mucosal lining that usually develops in the fossa of Rosenmüller. One of NPC’s initial signs is 
hearing loss. 
Objective: This study aims to determine the audiometry of patients with nasopharyngeal carcinoma in the ENT-
HN department of Mohammad Hoesin General Hospital Palembang 1 June 2016-1 June 2020. 
Methods: This research is a descriptive observational study with cross-sectional study design using medical 
records of patients with nasopharyngeal carcinoma at Mohammad Hoesin General Hospital Palembang 1 June 
2016 – 1 June 2020 who met the inclusion criteria. 
Results: From 48 samples, 42 samples (87,5%) were male, and 14 samples (29,2%) were included in the age 
range of 47-52 years. There were 18 samples (37,5%) suffering from a moderate degree of deafness. NPC 
patients mostly had conductive hearing loss (72,9%). Most of the sample suffered from bilateral hearing loss 
(75%). The majority of NPC patients had already been in stage IV (70,8%). It was found that NPC patients with 
stage IV suffered the most from conductive hearing loss (79,4%). 
Conclusion: NPC patients from 1 June 2016 – 1 June 2020 at ENT-HN Department of Mohammad Hoesin 
General Hospital Palembang were mostly male with an age range of 47-52 years who suffered from bilateral 
moderate conductive hearing loss and had already been in stage IV. It was found that most patients with stage 
IV of NPC had conductive hearing loss. 
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Nasopharyngeal Carcinoma (NPC) is a type of epithelial carcinoma 
arising from the mucosal layer of the nasopharynx, which usually develops in 
the fossa Rosenmüller [1, 2].  The early tumor development in the fossa 
Rosenmüller adjacent to the Eustachian tube causes hearing loss as one of 
NPC’s early symptoms. NPC patients usually ignore ear symptoms as they are 
non-specific symptoms. The appearance of a lump on the neck (swollen lymph 
nodes), which indicates advanced stage symptoms, is a symptom that often 
causes patients to see a doctor [3, 4]. 
The incidence of NPC is rare globally, where there is only 1/100.000 cases 
per year. However, in several countries in Southeast Asia and North Africa, 
NPC incidence is relatively high at 5-15/100.000 cases per year. The highest 
incidence of NPC was found in Southern China at 20/100.000 cases per year 
[2, 5]. NPC ranks fourth of all malignancies and ranks the first as most cancer 
cases in head and neck cancer cases in Indonesia. The incidence of NPC in 
Indonesia is estimated at 6.2/100.000 or 12.000 new cases per year [2, 6]. 
NPC’s early signs and symptoms are unilateral tinnitus, otalgia, nasal 
voice, hearing loss, nasal congestion, rhinorrhea, blood in the mucus, and 
epistaxis. However, location of the nasopharynx that tends to be hidden and 
the non-specific symptoms makes the tumor often late diagnosed [3, 4]. 
Staging classification based on AJCC by assessing the characteristics of the 
tumor, regional lymph nodes, and distant metastasis were divided into stages 
I, II, IVA, and IVB [7, 8].  
Ear symptoms in NPC are ear fullness, hearing loss, and tinnitus. The 
middle ear is the most often affected by NPC because it is connected to the 
nasopharynx by the Eustachian tube. Tumor in fossa Rosenmüller spread to 
the middle ear by Eustachian tube causing Eustachian tube dysfunction. 
Tumour can spread through the mucosa and submucosa or along with muscle 
in fibrofatty tissue or neurovascular. Persistent Eustachian tube dysfunction 
causes effusion in the middle ear with a symptom of conductive deafness, 
which is common in NPC patients [9, 10]. Audiometry test is one of the tools 
that can be done to support initial diagnosis, diagnose OME (otitis media 
effusion), and detect side effect of NPC patient’s medication. This study aims 
to know the type of deafness and the degree of hearing loss based on 
audiometric result in NPC patients. 
2. MATERIALS AND METHODS 
This research is a descriptive observational study with a cross-sectional 
design in the Medical Record Installation of dr. Mohammad Hoesin General 
Hospital Palembang which was held in November-December 2020. This 
study used secondary data (medical record) of NPC patients who met the 
inclusion and exclusion criteria. The inclusion criteria in this study were 
complete and accessible NPC patient medical record data. This study’s 
exclusion criteria were medical records of NPC patients who had undergone 
chemotherapy and radiation therapy at dr. Mohammad Hoesin General 
Hospital Palembang. Sampling was carried out by consecutive methods and 
obtained 24 NPC patients (48 ear samples) who met the inclusion and 
exclusion criteria. The collected data was then processed using The 
Statistical Package for the Social Sciences (SPSS) application version 24. 
3. RESULTS 
Table 1. Age Distribution 
Age N (patients) (%) 
23-28 2 8,3 
29-34 1 4,2 
35-40 3 12,5 
41-46 4 16,7 
47-52 7 29,2 
53-58 4 16,7 
59-64 3 12,5 
Total 24 100 
 
From 24 patients, there were 7 patients (29.2%) in 47-52 years age 
group, 4 patients (16.7%) each in 41-46 years and 53-58 years age group, 3 
patients (12.5%) respectively in 35-40 years and 59-63 years age group, 2 
patients (8.3%) in 23-28 years age group and 1 patients (4.2%) in 29-34 years 











Table 2. Gender  
Gender N (patients) (%) 
Female 3 12,5 
Male 21 87,5 
Total  24 100 
 
In this study, there were 21 males (87.5%) and 3 females (12.5%). The 
gender distribution of NPC patients is shown in table 2.  
Table 3. Degree of Hearing Loss 
Degree N (ears) (%) 
Normal 6 12,5 
Mild 11 22,9 
Moderate 18 37,5 
Moderately Severe 10 20,8 
Severe 2 4,2 
Profound 1 2,1 
Total 48 100 
 
The distribution of samples with moderate hearing loss was the 
highest as many as 18 ear samples (37.5%). The number of ear samples 
with mild hearing loss was relatively high as many as 11 ear samples 
(22.9%), followed by 10 ear samples (20.8%) with moderate hearing loss. 
The number of ear samples with severe hearing loss were 2 ear samples 
(4.2%) and the lowest was samples in profound hearing loss, namely 1 
sample (2.1%). The distribution of hearing loss degrees by ears can be 
seen in table 3. 
 
Table 4. Types of Hearing Loss 
Types N (ears) (%) 
Normal 6 12,5 
Conductive 35 72,9 
Sensorineural 1 2,1 
Mixed 6 12,5 
Total 48 100 
 
As can be seen in table 4, the distribution of samples with conductive 
hearing loss were the highest as many as 35 ear samples (72.9%), whereas 
the distribution of samples with sensorineural hearing loss was the lowest 
as many as 1 sample (2.1%). 
 
Table 5. Side of Hearing Loss 
Side N (patients) (%) 
Unilateral 6 25 
Bilateral 18 75 
Total 24 100 
 
There were 18 patients (75%) who suffered from bilateral hearing loss 
and 6 patients (25%) had unilateral hearing loss. The distribution of 
hearing loss side can be seen in table 5.  
 
Table 6. Stage 
Stage N (patients) (%) 
I 0 0 
II 2 8,3 
III 5 20,8 
IV 17 70,8 
Total 24 100 
 
Almost all patients had been diagnosed with stage IV as many as 17 
patients (70.8%), and none of the patient had been diagnosed with stage I. 
The number of patients with stage III were 5 patients (20.8%) and stage II 
were 2 patients (8.3%). The distribution of the stages in NPC patients can 
be seen in table 6.  
 
Table 7. Types of Hearing Loss Based on NPC Stages 
From 34 ear samples included in stage IV, most of the samples suffered 
from conductive hearing loss as many as 27 ear samples (79.4%). The 
distribution of the type of hearing loss based on the NPC stage can be seen 
in table 7. 
 
4. DISCUSSION 
In this study, NPC was mainly found in the 47-52 years age group 
(29.2%), which was similar to the previous studies. According to the 
literature, this states that NPC is most often detected in the age range of 30 
– 50 years [2]. This can occur because EBV infection can produce a virus 
that persists throughout the lifetime as a latent and lytic infection in B cell 
memory which can cause the target cells in the nasopharynx to be 
susceptible to carcinogenic substances in the environment and genetic 
changes that can cause NPC [11]. Aging can also increase the susceptibility 
of various tissues to the initiation of carcinogens and may facilitate the 
promotion and processing of carcinogenesis [12]. 
The majority of samples were male, as many as 21 patients (87.5%) 
with a male to female ratio of 7:1. This study’s result is similar to previous 
studies. According to the literature, NPC incidence is more common in men 
because of men’s lifestyle who are more often exposed to alcohol and 
cigarettes. Occupational factors also make men more often exposed to 
smoke, dust, steam, and carcinogenic chemicals that can transform the 
nasopharyngeal epithelium to malignancy. Another factor is estrogen in 
women, which is known to inhibit inflammatory responses that contribute 
to carcinogenesis [12, 13]. 
The majority of NPC patients in this study suffered from moderate 
degree hearing loss as many as 18 ear samples (37.5%). Different results 
were obtained in previous studies, showing that most NPC patients had 
normal hearing or experienced mild hearing loss. The majority of patients 
had mild and moderate hearing loss due to the continuous conduction 
process of Eustachian tube dysfunction, which is still new and not yet severe 
process in the middle ear [9]. 
This study shows that most of the samples suffer from conductive 
hearing loss as many as 35 ear samples (72.9%). A concordance was found 
in the study by Cahyadi et al. on 70 ear samples where the distribution of 
NPC patients with conductive hearing loss was the highest, as many as 36 
samples (51%) [9].  Conductive hearing loss can occur because of the 
tumor’s location in the fossa Rosenmüller adjacent to the Eustachian tube 
can cause Eustachian tube dysfunction. Eustachian tube dysfunction 
disrupts the aeration function that regulates the balance between the air 
pressure in the middle ear and the outside eardrum.  Middle ear effusions 
are caused by the inability to enter air into the tubes because nasopharyngeal 
tumors damage m. tensor veli palatini, causing an increase in negative 
pressure on the middle ear. The negative pressure in the middle ear caused 
by the absorption and diffusion of oxygen and nitrogen to mucous cells will 
cause the accumulation of serous fluid (sterile effusion), resulting in OME 
[9, 11, 14, 15]. 
Based on the side of hearing loss, it was found that the majority of the 
sample suffered from bilateral hearing loss compared to unilateral hearing 
loss with a ratio of 3:1. This study isn’t in line with previous studies, which 
showed that most NPC patients suffered from unilateral hearing loss. The 
difference in the study’s result is thought to be due to differences in the 
expansion of nasopharyngeal tumors. 
The majority of NPC patients in this study were in stage IV. This is in 
line with the literature, which states that many NPC patients are diagnosed 
late due to non-specific signs and symptoms at an early stage and the 
difficulty of examining the nasopharynx. Therefore, most patients see a 
doctor at an advanced stage [16]. The initial symptoms of NPC were similar 
to the common symptoms of upper respiratory tract infection (URTI), which 
led doctors to rule out NPC as the main diagnosis. Lack of education about 
NPC symptoms, poor economy, and lack of awareness to see a doctor are 
other factors of the delay in diagnosing NPC. Limited diagnostic tools is 
also one of the obstacles in diagnosing NPC [3]. 
In this study, it was found that the samples in stage IV category with 
conductive deafness were the highest as many as 27 ear samples from 34 ear 
samples in stage IV NPC patients (79.4%). Ear symptoms are one of the 
earliest symptoms by NPC patients. Initially, the tumor usually develops in 
the fossa Rosenmüller and can cover the Eustachian tube resulting to hearing 
loss, otalgia, tinnitus, and ear fullness, but usually the patient will ignore 
non-specific ear symptoms. The appearance of a lump in the neck (enlarged 
lymph nodes), which is an advanced symptom of NPC is a symptom that 
usually causes patients to see a doctor [ 9, 16].  
 
Stage I Stage II Stage III Stage IV 
N % N % N % N % 
Normal 0 0 1 25 2 20 3 8,8 
Conductive 0 0 0 0 8 80 27 79,4 
Sensorineural 0 0 0 0 0 0 1 2,9 
Mixed 0 0 3 75 0 0 3 8,8 
Total 0 0 4 100 10 100 34 100 








This study shows that NPC patients often experience moderate 
conductive hearing loss. The majority of patients with conductive hearing 
loss is in the stage IV. It’s suggested to do further research regarding 
audiometric result in nasopharyngeal carcinoma patients which hasn’t been 
studied in this study. It’s hoped that health workers will conduct 
socialization to increase public awareness of the early symptoms of NPC so 
that early treatment can be done and increase patient life expectancy.  
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